PembrolizumabPembrolizumab is a humanized monoclonal antibody directed at programmed death-1 (PD-1) receptor, a negative regulator of T-cell activity. Pembrolizumab potentiates T-cell responses, including anti-tumour responses.
What can Sanquin do for you?
- Measure drug levels of free drug in the serum using an validated ELISA.
- Measure the immunogenicity of pembrolizumab.
- Provide assay reagents or co-develop novel testing strategies.
- Folllowing ISO, FDA/EMA, RUO guidelines.
Enquire about our drug level and ADA assays by emailing us at [email protected].